Cross-sectional Hospital-based Investigation on Clinical Characteristics of Pediatric Staphylococcus aureus Isolates in a Beijing Hospital from 2013 to 2022.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2024-11-06 eCollection Date: 2024-01-01 DOI:10.2147/IDR.S486832
LuWei Wang, Jing-Hui Zhen, Fang Dong, Zhi-Yong Lyu
{"title":"Cross-sectional Hospital-based Investigation on Clinical Characteristics of Pediatric <i>Staphylococcus aureus</i> Isolates in a Beijing Hospital from 2013 to 2022.","authors":"LuWei Wang, Jing-Hui Zhen, Fang Dong, Zhi-Yong Lyu","doi":"10.2147/IDR.S486832","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Staphylococcus aureus</i> (<i>S. aureus</i>) was a prevalent pathogenic bacterium among children. Due to the extensive use of antibiotics, the sensitivity of <i>S. aureus</i> to these drugs has gradually declined. Since the 1960s, methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) has emerged and spread worldwide, becoming a primary cause of both healthcare-associated (HA) and community-acquired (CA) infections. This retrospective study aimed to highlight the significance of <i>S. aureus</i> among bacteria isolated from children in Beijing, China, and to elucidate its antimicrobial resistance patterns.</p><p><strong>Methods: </strong>Data on all <i>S. aureus</i> infections from 2013 to 2022 were collected from the microbiology department of Beijing Children's Hospital. Only the first isolate from the same kind of specimen was analyzed. Antimicrobial susceptibility tests were carried out by Vitek 2 automated system (bio Mérieux, France) or Kirby-Bauer disc diffusion method, according to the guidelines recommended by the Clinical and Laboratory Standards Institute (CLSI).</p><p><strong>Results: </strong>During the decade-long research period, a total of 47,062 bacterial isolates were isolated from 433,081 submitted specimens, with 6477 of these isolates identified as <i>S. aureus</i>. The majority of patients with <i>S. aureus</i> infections belonged to the age group of infants under one-year-old, accounting for 37.9% of cases. <i>S. aureus</i> isolates were predominantly found in the Pneumology Department, and the most common source of these isolates was lower respiratory tract specimens, comprising 34.3% of the total. The resistance rates of <i>S. aureus</i> to penicillin and erythromycin were notably high, at 89.5% and 73.8%, respectively. In contrast, the resistance rates to linezolid, vancomycin, rifampicin, and moxifloxacin were remarkably low, at 0.0%, 0.0%, 1.3%, and 3.9%, respectively. The detection rate of MRSA was 27.8%. MRSA isolates were predominantly found in the newborn group, ICU, and sterile body fluids.</p><p><strong>Conclusion: </strong>In our study, the most prevalent specimen type was derived from the lower respiratory tract, whereas the highest positive rate was observed in ear secretions. These findings underscored the pressing necessity for ongoing antimicrobial resistance (AMR) surveillance and the revision of treatment guidelines, particularly given the elevated detection of MRSA in ICU wards, sterile body fluids, and the neonatal age group. MRSA exhibited significant resistance to all β-lactam antibiotics, erythromycin, and ciprofloxacin. Therefore, future research endeavors should prioritize examining specific antimicrobial resistance populations and potential intervention strategies, as these were vital in mitigating the dissemination of antimicrobial-resistant isolates.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"17 ","pages":"4899-4912"},"PeriodicalIF":2.9000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550683/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S486832","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Staphylococcus aureus (S. aureus) was a prevalent pathogenic bacterium among children. Due to the extensive use of antibiotics, the sensitivity of S. aureus to these drugs has gradually declined. Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged and spread worldwide, becoming a primary cause of both healthcare-associated (HA) and community-acquired (CA) infections. This retrospective study aimed to highlight the significance of S. aureus among bacteria isolated from children in Beijing, China, and to elucidate its antimicrobial resistance patterns.

Methods: Data on all S. aureus infections from 2013 to 2022 were collected from the microbiology department of Beijing Children's Hospital. Only the first isolate from the same kind of specimen was analyzed. Antimicrobial susceptibility tests were carried out by Vitek 2 automated system (bio Mérieux, France) or Kirby-Bauer disc diffusion method, according to the guidelines recommended by the Clinical and Laboratory Standards Institute (CLSI).

Results: During the decade-long research period, a total of 47,062 bacterial isolates were isolated from 433,081 submitted specimens, with 6477 of these isolates identified as S. aureus. The majority of patients with S. aureus infections belonged to the age group of infants under one-year-old, accounting for 37.9% of cases. S. aureus isolates were predominantly found in the Pneumology Department, and the most common source of these isolates was lower respiratory tract specimens, comprising 34.3% of the total. The resistance rates of S. aureus to penicillin and erythromycin were notably high, at 89.5% and 73.8%, respectively. In contrast, the resistance rates to linezolid, vancomycin, rifampicin, and moxifloxacin were remarkably low, at 0.0%, 0.0%, 1.3%, and 3.9%, respectively. The detection rate of MRSA was 27.8%. MRSA isolates were predominantly found in the newborn group, ICU, and sterile body fluids.

Conclusion: In our study, the most prevalent specimen type was derived from the lower respiratory tract, whereas the highest positive rate was observed in ear secretions. These findings underscored the pressing necessity for ongoing antimicrobial resistance (AMR) surveillance and the revision of treatment guidelines, particularly given the elevated detection of MRSA in ICU wards, sterile body fluids, and the neonatal age group. MRSA exhibited significant resistance to all β-lactam antibiotics, erythromycin, and ciprofloxacin. Therefore, future research endeavors should prioritize examining specific antimicrobial resistance populations and potential intervention strategies, as these were vital in mitigating the dissemination of antimicrobial-resistant isolates.

2013-2022年北京某医院小儿金黄色葡萄球菌临床特征的医院横断面调查。
背景:金黄色葡萄球菌(S. aureus)是儿童中普遍存在的致病菌。由于抗生素的广泛使用,金黄色葡萄球菌对这些药物的敏感性逐渐下降。自 20 世纪 60 年代以来,耐甲氧西林金黄色葡萄球菌(MRSA)在全球范围内出现并蔓延,成为医源性(HA)和社区获得性(CA)感染的主要病因。这项回顾性研究旨在强调金黄色葡萄球菌在中国北京儿童细菌分离中的重要性,并阐明其抗菌药耐药性模式:方法:从北京儿童医院微生物科收集 2013 年至 2022 年所有金黄色葡萄球菌感染的数据。仅分析同类标本中的第一个分离株。根据临床和实验室标准协会(CLSI)推荐的指南,采用 Vitek 2 自动系统(法国生物梅里埃公司)或柯比-鲍尔盘扩散法进行抗菌药物敏感性检测:在长达十年的研究期间,从 433,081 份送检标本中共分离出 47,062 株细菌,其中 6477 株被鉴定为金黄色葡萄球菌。大部分金黄色葡萄球菌感染患者属于一岁以下婴儿,占病例总数的 37.9%。金黄色葡萄球菌分离株主要出现在肺炎部,最常见的分离株来源是下呼吸道标本,占总数的 34.3%。金黄色葡萄球菌对青霉素和红霉素的耐药率明显较高,分别为 89.5%和 73.8%。相比之下,金黄色葡萄球菌对利奈唑胺、万古霉素、利福平和莫西沙星的耐药率极低,分别为 0.0%、0.0%、1.3% 和 3.9%。MRSA 的检出率为 27.8%。MRSA分离株主要出现在新生儿组、重症监护室和无菌体液中:结论:在我们的研究中,最常见的标本类型来自下呼吸道,而耳分泌物的阳性率最高。这些发现强调了持续监测抗菌药耐药性(AMR)和修订治疗指南的紧迫性,特别是考虑到在重症监护病房、无菌体液和新生儿年龄组中MRSA的检出率较高。MRSA对所有β-内酰胺类抗生素、红霉素和环丙沙星均表现出明显的耐药性。因此,未来的研究工作应优先考察特定的抗菌药耐药人群和潜在的干预策略,因为这些对于减少抗菌药耐药分离物的传播至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信